RecruitingPhase 3ACTRN12608000159358
Effects of antioxidant supplementation with Astaxanthin on blood vessels in renal transplant patients
Effects of supplementation with Astaxanthin on oxidative stress and vascular structure and function in renal transplant patients
Sponsor
Launceston General Hospital
Enrollment
44 participants
Start Date
Sep 1, 2006
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 18 YearssMax Age: 85 Yearss
Inclusion Criteria1
- Have undergone a renal transplant
Exclusion Criteria1
- Individuals currently taking antioxidant supplements or have AV fistulas in both arms or are unable to be given anginine or participation or proposed participation in another clinical investigational drug study within 30 days prior to study entry.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Astaxanthin 4 mg tablets, 3 tablets daily over 12 months
Astaxanthin 4 mg tablets, 3 tablets daily over 12 months
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12608000159358
Related Trials
Vascular Disease Discovery Protocol
NCT035386391 location
PMPR and Chlorhexidine on Periodontal Disease and Vascular Function
NCT073115121 location
The Effect of Emotion-Focused Intervention on Emotion Regulation and Well-Being of Individuals With Transplantation
NCT072941831 location
Remimazolam Infusion in Kidney Transplant Patients: A Multicenter Study
NCT070454671 location
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
NCT060265921 location